XML 98 R78.htm IDEA: XBRL DOCUMENT v3.23.4
Long-Term Investments (Details) - Schedule of Balance Sheet - USD ($)
 9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Dec. 31, 2022
Dec. 31, 2021
BioFirst [Member]        
Condensed Balance Sheet Statements, Captions [Line Items]        
Current Assets $ 1,690,060 $ 1,543,152 $ 1,543,152  
Noncurrent Assets 651,221 739,472 739,472  
Current Liabilities 2,236,708 2,663,051 2,663,051  
Noncurrent Liabilities 366,634 103,447 103,447  
Stockholders’ Equity (Deficit) (262,061) (483,874)    
BioFirst [Member] | Previously Reported [Member]        
Condensed Balance Sheet Statements, Captions [Line Items]        
Current Assets   1,543,151 1,543,151 $ 2,205,669
Noncurrent Assets   739,472 739,472 959,454
Current Liabilities   2,663,051 2,663,051 2,909,703
Noncurrent Liabilities   103,447 103,447 32,522
Stockholders’ Equity (Deficit)     483,874 222,898
Rgene [Member]        
Condensed Balance Sheet Statements, Captions [Line Items]        
Current Assets 56,091 68,302 68,302 73,452
Noncurrent Assets 239,594 303,893 303,893 374,423
Current Liabilities 2,407,204 2,478,868 2,478,868 1,934,786
Noncurrent Liabilities 1,465 2,441 2,441
Stockholders’ Equity (Deficit) $ (2,112,984) $ (2,109,114) $ (2,481,309) $ (1,486,911)